295 related articles for article (PubMed ID: 27109610)
1. Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6.
Yao XM; Liu YJ; Wang YM; Wang H; Zhu BB; Liang YP; Yao WG; Yu H; Wang NS; Zhang XM; Peng W
Mol Med Rep; 2016 Jun; 13(6):5149-56. PubMed ID: 27109610
[TBL] [Abstract][Full Text] [Related]
2. NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression.
Li R; Zhang L; Shi W; Zhang B; Liang X; Liu S; Wang W
Exp Cell Res; 2013 Apr; 319(7):992-1000. PubMed ID: 23340267
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF‑κB pathway under high glucose conditions.
Sun L; Li W; Li W; Xiong L; Li G; Ma R
Int J Mol Med; 2014 Jul; 34(1):167-76. PubMed ID: 24718766
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.
Ma R; Wang Y; Xu Y; Wang R; Wang X; Yu N; Li M; Zhou Y
J Diabetes Res; 2021; 2021():8832114. PubMed ID: 34095318
[TBL] [Abstract][Full Text] [Related]
6. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
[TBL] [Abstract][Full Text] [Related]
7. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.
Ma R; Liu L; Jiang W; Yu Y; Song H
Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720
[TBL] [Abstract][Full Text] [Related]
8. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV ameliorates diabetic nephropathy in
Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase 4 mediates high glucose-induced podocyte apoptosis via upregulation of calcineurin.
Shi W; Huang Y; Zhao X; Xie Z; Dong W; Li R; Chen Y; Li Z; Wang W; Ye Z; Liu S; Zhang L; Liang X
Biochem Biophys Res Commun; 2020 Dec; 533(4):1061-1068. PubMed ID: 33019979
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
[TBL] [Abstract][Full Text] [Related]
13. RANK Deficiency Ameliorates Podocyte Injury by Suppressing Calcium/Calcineurin/ NFATc1 Signaling.
Liang S; Zhang H; Du Y; Dou C; Liu S; Zhang L; Chen Y; Li R; Ma J; Li Z; Lin T; Zhao X; Zhang Q; Wang W; Ye Z; Liang X; Shi W; Zhang B
Kidney Blood Press Res; 2018; 43(4):1149-1159. PubMed ID: 30036881
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
15. Gq signaling causes glomerular injury by activating TRPC6.
Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway.
Lei X; Zhang BD; Ren JG; Luo FL
Life Sci; 2018 Aug; 206():77-83. PubMed ID: 29792879
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats.
Lei X; Zhang L; Li Z; Ren J
Drug Des Devel Ther; 2018; 12():2785-2793. PubMed ID: 30233141
[TBL] [Abstract][Full Text] [Related]
18. The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis.
Zhang HT; Wang WW; Ren LH; Zhao XX; Wang ZH; Zhuang DL; Bai YN
Cell Physiol Biochem; 2016; 40(5):1079-1093. PubMed ID: 27960162
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
Li Z; Xu J; Xu P; Liu S; Yang Z
Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
